The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of DNA sequencing, immunohistochemistry, and in-situ hybridization techniques to determine HER2 status in metastatic breast cancer patients.
 
Lincy S. Lal
Employment - ConcertAI; Optum/UnitedHealth Group
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); BMS (Inst); Daiichi Sankyo/UCB Japan (Inst); Gilead Sciences (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst)
 
Dana Milne
Employment - Oncology Analytics
Stock and Other Ownership Interests - Oncology Analytics
 
Mark S. Walker
Employment - ConcertAI
Stock and Other Ownership Interests - ConcertAI
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Eisai (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Seagen (Inst)
 
Marina Kovach
Employment - ConcertAI